UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 307

Sortiert nach

The angiotensin II type 1 receptor-neprilysin inhibitor LCZ696 blocked aldosterone synthesis in a human adrenocortical cell line

Hypertension research, 2016-11, Vol.39 (11), p.758-763

2016

Link zum Volltext

Verfügbarkeit prüfen

Changes in the function of angiotensin II type 1 receptor due to cholesterol depletion from cell membrane

Biochemical and biophysical research communications, 2019-06, Vol.514 (3), p.791-797

2019

Link zum Volltext

Verfügbarkeit prüfen

Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide

International journal of cardiology, 2019-12, Vol.297, p.111-117

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of Cigarette Smoking Cessation on High-Density Lipoprotein Functionality: VN-SEESAW-HDL

Circulation Journal, 2014/11/25, Vol.78(12), pp.2955-2962

2014

Link zum Volltext

Verfügbarkeit prüfen

Development of a Non-Peptide Angiotensin II Type 1 Receptor Ligand by Structural Modification of Olmesartan as a Biased Agonist

Biomedicines, 2023-05, Vol.11 (5), p.1486

2023

Link zum Volltext

Verfügbarkeit prüfen

Advanced glycation of high-density lipoprotein and the functionality of aldosterone release in type 2 diabetes

Hypertension research, 2017-03, Vol.40 (3), p.271-276

2017

Link zum Volltext

Verfügbarkeit prüfen

Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan

Hypertension research, 2013-02, Vol.36 (2), p.134-139

2013

Link zum Volltext

Verfügbarkeit prüfen

Unique mode of binding between angiotensin II type 1 receptor and its blockers

Clinical and experimental hypertension (1993), 2019-11, Vol.41 (8), p.747-752

2019

Link zum Volltext

Verfügbarkeit prüfen

Molecular Mechanism Underlying Inverse Agonist of Angiotensin II Type 1 Receptor

The Journal of biological chemistry, 2006-07, Vol.281 (28), p.19288-19295

2006

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanisms of the antagonistic action between AT1 and AT2 receptors

Biochemical and biophysical research communications, 2010-01, Vol.391 (1), p.85-90

2010

Link zum Volltext

Verfügbarkeit prüfen

Reassessment of the unique mode of binding between angiotensin II type 1 receptor and their blockers

PloS one, 2013-11, Vol.8 (11), p.e79914

2013

Link zum Volltext

Verfügbarkeit prüfen

Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element

Atherosclerosis, 2007-03, Vol.191 (1), p.11-21

2007

Link zum Volltext

Verfügbarkeit prüfen

Differential Bonding Interactions of Inverse Agonists of Angiotensin II Type 1 Receptor in Stabilizing the Inactive State

Molecular endocrinology (Baltimore, Md.), 2008-01, Vol.22 (1), p.139-146

2008

Link zum Volltext

Verfügbarkeit prüfen

Small molecules with similar structures exhibit agonist, neutral antagonist or inverse agonist activity toward angiotensin II type 1 receptor

PloS one, 2012-06, Vol.7 (6), p.e37974-e37974

2012

Link zum Volltext

Verfügbarkeit prüfen

The ApoA-I mimetic peptide FAMP promotes recovery from hindlimb ischemia through a nitric oxide (NO)-related pathway

International journal of cardiology, 2016-03, Vol.207, p.317-325

2016

Link zum Volltext

Verfügbarkeit prüfen

Addition of a Nitric Oxide Donor to an Angiotensin II Type 1 Receptor Blocker May Cancel Its Blood Pressure-Lowering Effects

International Heart Journal, 2015, Vol.56(6), pp.656-660

2015

Link zum Volltext

Verfügbarkeit prüfen

Transactivation of KDR/Flk-1 by the B2 Receptor Induces Tube Formation in Human Coronary Endothelial Cells

Hypertension (Dallas, Tex. 1979), 2003-05, Vol.41 (5), p.1118-1123

2003

Link zum Volltext

Verfügbarkeit prüfen

Antiarrhythmogenic Effect of Reconstituted High-Density Lipoprotein Against Ischemia/Reperfusion in Rats

Journal of the American College of Cardiology, 2008-04, Vol.51 (16), p.1604-1612

2008

Link zum Volltext

Verfügbarkeit prüfen

Correction: Small Molecules with Similar Structures Exhibit Agonist, Neutral Antagonist or Inverse Agonist Activity toward Angiotensin II Type 1 Receptor

PloS one, 2013-05, Vol.8 (5)

2013

Link zum Volltext

Verfügbarkeit prüfen

Nifedipine-induced vascular endothelial growth factor secretion from coronary smooth muscle cells promotes endothelial tube formation via the kinase insert domain-containing receptor/fetal liver kinase-1/NO pathway

Hypertension research, 2005-02, Vol.28 (2), p.147-153

2005

Link zum Volltext

Verfügbarkeit prüfen

High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells

Arteriosclerosis, thrombosis, and vascular biology, 2003-05, Vol.23 (5), p.802

2003

Link zum Volltext

Verfügbarkeit prüfen

Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation

Atherosclerosis, 2007-09, Vol.194 (1), p.159-168

2007

Link zum Volltext

Verfügbarkeit prüfen

Jun N-Terminal Kinase Inhibitor Blocks Angiogenesis by Blocking VEGF Secretion and an MMP Pathway

Journal of Atherosclerosis and Thrombosis, 2008, Vol.15(2), pp.69-74

2008

Link zum Volltext

Verfügbarkeit prüfen

Activation of Extracellular Signal-Activated Kinase by Angiotensin II-Induced Gq-Independent Epidermal Growth Factor Receptor Transactivation

Hypertension Research, 2004, Vol.27(10), pp.765-770

2004

Link zum Volltext

Verfügbarkeit prüfen

Reconstituted high-density lipoprotein attenuates postinfarction left ventricular remodeling in rats

Atherosclerosis, 2009-03, Vol.203 (1), p.137-144

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 307

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(246)
Mit Volltextzugriff
(275)

Publikationsform

Sprache

Englisch
(277)
Japanisch
(119)

Erscheinungsjahr

n.n

Thema

Science & Technology
(173)
Life Sciences & Biomedicine
(139)
Humans
(135)
Male
(63)
Female
(61)
Biological And Medical Sciences
(49)
Animals
(47)
Middle Aged
(42)
Cardiovascular System & Cardiology
(36)
Adult
(35)
Medical Sciences
(35)
Aged
(34)
Oncology
(25)
Cardiac & Cardiovascular Systems
(21)
Peripheral Vascular Disease
(21)
Physical Sciences
(20)
Fundamental And Applied Biological Sciences. Psychology
(19)
Mice
(18)
Physics
(18)
Cells, Cultured
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The angiotensin II type 1 receptor-neprilysin inhibitor LCZ696 blocked aldosterone synthesis in a human adrenocortical cell line

Changes in the function of angiotensin II type 1 receptor due to cholesterol depletion from cell membrane

Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide

Impact of Cigarette Smoking Cessation on High-Density Lipoprotein Functionality: VN-SEESAW-HDL

Development of a Non-Peptide Angiotensin II Type 1 Receptor Ligand by Structural Modification of Olmesartan as a Biased Agonist

Advanced glycation of high-density lipoprotein and the functionality of aldosterone release in type 2 diabetes

Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan

Unique mode of binding between angiotensin II type 1 receptor and its blockers

Molecular Mechanism Underlying Inverse Agonist of Angiotensin II Type 1 Receptor

Molecular mechanisms of the antagonistic action between AT1 and AT2 receptors

Reassessment of the unique mode of binding between angiotensin II type 1 receptor and their blockers

Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element

Differential Bonding Interactions of Inverse Agonists of Angiotensin II Type 1 Receptor in Stabilizing the Inactive State

Small molecules with similar structures exhibit agonist, neutral antagonist or inverse agonist activity toward angiotensin II type 1 receptor

The ApoA-I mimetic peptide FAMP promotes recovery from hindlimb ischemia through a nitric oxide (NO)-related pathway

Addition of a Nitric Oxide Donor to an Angiotensin II Type 1 Receptor Blocker May Cancel Its Blood Pressure-Lowering Effects

Transactivation of KDR/Flk-1 by the B2 Receptor Induces Tube Formation in Human Coronary Endothelial Cells

Antiarrhythmogenic Effect of Reconstituted High-Density Lipoprotein Against Ischemia/Reperfusion in Rats

Correction: Small Molecules with Similar Structures Exhibit Agonist, Neutral Antagonist or Inverse Agonist Activity toward Angiotensin II Type 1 Receptor

Nifedipine-induced vascular endothelial growth factor secretion from coronary smooth muscle cells promotes endothelial tube formation via the kinase insert domain-containing receptor/fetal liver kinase-1/NO pathway

High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells

Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation

Jun N-Terminal Kinase Inhibitor Blocks Angiogenesis by Blocking VEGF Secretion and an MMP Pathway

Activation of Extracellular Signal-Activated Kinase by Angiotensin II-Induced Gq-Independent Epidermal Growth Factor Receptor Transactivation

Reconstituted high-density lipoprotein attenuates postinfarction left ventricular remodeling in rats

Suchergebnisse filtern